Sealed Air Enters $10.3 Billion Acquisition Agreement with Clayton, Dubilier & Rice
Sealed Air Corporation (NYSE:SEE) has entered into a definitive agreement to be acquired by private investment firm Clayton, Dubilier & Rice (CD&R) in an all-cash transaction valued at $10.3 billion. The agreement offers Sealed Air stockholders $42.15 per share, which represents a 41% premium over the company's unaffected share price.
Following the news, Stifel Nicolaus set a price target of $45 for Sealed Air. The company's stock is currently trading at $43.28, reflecting an increase of $0.78, or 1.84%. The price target from Stifel suggests a potential upside of approximately 3.97% from the current trading price.
During the day's trading, the stock has seen a low of $42.08 and a high of $43.47. Over the past 52 weeks, Sealed Air's stock has ranged from a low of $22.78 to a high of $44.27. The company's market capitalization is approximately $6.37 billion, with a trading volume of 5.78 million shares.
For more information on the company, see its history and ownership, mission and vision, financial health, and investor profile.
Sealed Air Corporation (SEE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.